Pakistan

Oxford vaccine update: name of the Serum Institute recommended for phase 2 and human trials of the COVID-19 candidate vaccine

Oxford Vaccine Update: The first two-phase trials of the Covishield COVID-19 vaccine in the UK showed that it had an appropriate protective profile and a homologous accumulation in the antibody response.

Oxford vaccine update: name of the Serum Institute recommended for phase 2 and human trials of the COVID-19 candidate vaccine Read More »